| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102474 Dietetics; antidiabetic agents; eating disorders |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102447 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102439 Halogenobenzyl aminopropionic acid derivatives |
| 05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102417 Reaction product of carborane and vitamin d; therapy for vitamin deficiency diseases |
| 05/27/2004 | US20040102362 Protocol for paracentesis |
| 05/27/2004 | US20040101934 Beverage comprising peptide nerve growth factor conjugate for use in treatment of pain; analgesics; tranquilizers |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101875 Novel g protein-coupled receptor protein and dna thereof |
| 05/27/2004 | US20040101837 Nucleotide sequences coding for proteins involved in the biosynthesis of L-serine, an improved method for the microbial production of L-serine and a genetically modified microorganism suitable therefor |
| 05/27/2004 | US20040101575 Comprehensive pharmacologic therapy for treatment of obesity |
| 05/27/2004 | US20040101544 Method for detoxifying a carbohydrate containing solution |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | CA2505372A1 Fused heterocyclic compounds |
| 05/27/2004 | CA2505249A1 N-sulfonylaminothiazole |
| 05/27/2004 | CA2504008A1 Novel imidazopyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 05/27/2004 | CA2503995A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 05/27/2004 | CA2503992A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/26/2004 | EP1422524A1 Screening method |
| 05/26/2004 | EP1422224A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421945A1 Bile acid absorbent/adsorbent |
| 05/26/2004 | EP1421937A1 Use of amino acids for making medicines for treating insulin-resistance |
| 05/26/2004 | EP1421933A1 Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421182A1 Methods of inducing differentiation of stem cells |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421078A1 Beta-3 adrenergic agonists |
| 05/26/2004 | EP1421077A2 Novel pyrazole analogs acting on cannabinoid receptors |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1421061A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 05/26/2004 | EP1420826A2 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420812A1 Use of leptin for infant with low birth weight for prevention of obesity |
| 05/26/2004 | EP1420802A1 Increased solubility flavanolignan preparations |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420799A2 Use of atazanavir in hiv therapy |
| 05/26/2004 | EP1420798A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420794A1 Prostaglandin analogs as chloride channel opener |
| 05/26/2004 | EP1420790A1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine |
| 05/26/2004 | EP1420788A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420774A1 Preparation and diabetic use of gibberellins |
| 05/26/2004 | EP1420773A1 Amidine derivatives for treating amyloidosis |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420771A2 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 05/26/2004 | EP1420769A2 Lipid profile modulation with steroids |
| 05/26/2004 | EP1420657A1 Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
| 05/26/2004 | EP1420643A2 Enhancement of transfection of dna into the liver |
| 05/26/2004 | EP1328269B1 Association of a cb1 receptor antagonist and sibutramin for treating obesity |
| 05/26/2004 | EP1322315A4 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1173176B1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 05/26/2004 | EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 05/26/2004 | EP1022272B1 Substituted fused heterocyclic compounds |
| 05/26/2004 | EP0932410B1 Mistletoe (viscum) extracts |
| 05/26/2004 | EP0676205B1 Cerebral metabolism activator containing glucose ester derivative |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1500088A Isoquinuclidine derivative, process for producing same, and medicinal compsn. contg. same |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1499971A Novel use of arylethene sulfonamide derivative |
| 05/26/2004 | CN1499936A Mixtures of fructose and lactose as low-calorie bulk sweetener with reduced glycemic index |
| 05/26/2004 | CN1498902A Immune suppression fusion protein, its coded nucleic acid and application |
| 05/26/2004 | CN1498892A Extract of general glycoside in picrorhiza rhizome as well as preparation method and application |
| 05/26/2004 | CN1498823A Oil refine and filling system |
| 05/26/2004 | CN1498659A Nutritious supplementing agent contg. a-glucosidase inhibitor and a-amylase inhibitor |
| 05/26/2004 | CN1498653A Extract of 'Sheganguo' and its prepn. method |
| 05/26/2004 | CN1498639A Chinese traditional medicine to be taken after being mixed with boiling water for reducing blood fat |
| 05/26/2004 | CN1498616A Compsns. for lowering cholesterol |
| 05/26/2004 | CN1498612A Medicament form of tatin class |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151140C Glucokinase activators |
| 05/26/2004 | CN1151139C Novel heterocyclic analogs of diphenylethylene compounds |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1150942C Capsule for cleaning blood and reducing fat |
| 05/26/2004 | CN1150937C Chinese medicine composition with functions of regulating blood-liquid and curing chemical liver injury |
| 05/26/2004 | CN1150837C Hypoglycmic-hypolipemic bean |
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |